TRIUMPH-2 studied 1,152 adults with type 2 diabetes and obesity or overweight, with an average baseline weight of 106.4 kg and average HbA1c of 7.7 per cent
In clinical use, it may be prescribed by healthcare professionals to help manage conditions linked to oxidative damage or to support recovery where antioxidant levels are reduced
Safety monitoring for cardiovascular parameters is conducted within the clinical trial setting
Oxidative stress is a major factor that leads to cell aging
It is also explored by patients who suffer from gastrointestinal problems such as inflammatory bowel disease (IBD), ulcers, or leaky gut syndrome, as it may help repair the gut lining and reduce inflammation in the digestive system
Product Overview Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide) is a premium research compound widely utilized in various scientific studies